Abiraterone
NDC 72789-213, Abiraterone acetate, tablet, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 72789-213
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208339
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72789-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72789-213-98 | 72789021398 | 120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/413c645e-074d-4276-b39a-d83521077602
Use it
Look up 72789-213 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72789-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72789-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.